DocGo Inc. DCGO

FY2025 · ended Dec 31, 2025 · Revenue $322.20M, -47.7% YoY · Filed Mar 16, 2026

DocGo Inc. (DCGO) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $322.2 million and a net loss of $182.4 million. Free cash flow was $29.9 million. As of Jun 30, 2026 it held $25.2 million in cash and investments and $25.9 million in total debt.

Revenue (TTM)
$294.72M
-32.4% vs year-ago TTM
Net income (TTM)
$-192.42M
Operating cash flow (TTM)
$-22.71M
-126.1% vs year-ago TTM
Free cash flow (TTM)
$-25.83M
-131.0% vs year-ago TTM
EPS (TTM)
$-1.96
Dividend per share
None
Shares outstanding
98.75M
-3.2% vs prior year
Net cash
$-672,808
as of Jun 30, 2026
Operating margin
-62.2%
FY 2026

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
DCGO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1822359
Former names
Motion Acquisition Corp. (until Nov 5, 2021)

Other Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$322.2M
$616.6M
$624.3M
$440.5M
$318.7M
Operating income
-$178.0M
$28.7M
$15.1M
$21.8M
$15.4M
Net income
-$182.4M
—
—
$34.6M
$23.7M
Diluted EPS
-$1.84
$0.18
$0.06
$0.34
$0.25
Operating cash flow
$34.5M
$70.1M
-$64.5M
$28.9M
-$1.9M
Free cash flow
$29.9M
$66.5M
-$71.8M
$25.7M
-$6.8M
Total assets
$217.1M
$455.6M
$490.5M
$393.3M
$309.6M
Total liabilities
$91.2M
$140.4M
$185.3M
$114.4M
$82.5M
Stockholders' equity
$144.0M
$320.9M
$300.8M
$273.2M
$219.6M
Cash and investments
$51.0M
$89.2M
$59.3M
$157.3M
$175.5M
Total debt
$29.2M
$27.2M
$21.5M
$18.7M
$15.2M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
Oct 5, 2026 Oct 1, 2026
10-Q Quarterly report Aug 17, 2026 Jun 30, 2026
8-K Current report
Material agreement, Results of operations
Aug 17, 2026 Aug 16, 2026
8-K Current report
Listing notice
Jul 31, 2026 Jul 28, 2026
8-K Current report
Regulation FD disclosure
Jul 2, 2026 Jun 26, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 16, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.